The implementation of whole-genome sequencing (WGS) as a clinical test has been a source of speculation, anticipation, and anecdotes for many years. The first clinical (CLIA-certified, CAP-accredited) laboratory to offer this test launched the service in 2009, and despite several significant challenges that still surround the offering and use of WGS for clinical applications, it has largely been embraced by an enthusiastic community of physicians and clinical laboratorians. In this chapter, we discuss the many considerations, caveats, challenges, and opportunities that must be addressed when implementing clinical WGS. Approaches to this implementation are also discussed. The chapter is organized into sections on test definition, staffing and training, infrastructure, validations, and interpretation and reporting considerations.
CITATION STYLE
Hambuch, T. M., Nykamp, K., & Mead, C. L. R. (2018). Implementation of Genome Sequencing Assays. In Genomic Applications in Pathology: Second Edition 2019 (pp. 219–236). Springer International Publishing. https://doi.org/10.1007/978-3-319-96830-8_18
Mendeley helps you to discover research relevant for your work.